Haslam A - Search Results

1

COVID-19 vaccines: history of the pandemic's great scientific success and flawed policy implementation.

Prasad V, Haslam A. Prasad V, et al. Among authors: haslam a. Monash Bioeth Rev. 2024 Mar 9. doi: 10.1007/s40592-024-00189-z. Online ahead of print. Monash Bioeth Rev. 2024. PMID: 38459404

2

Prevalence and predictors of anemia in a population-based study of octogenarians and centenarians in Georgia.

Haslam A, Hausman DB, Johnson MA, Davey A, Poon LW, Allen RH, Stabler SP; Georgia Centenarian Study. Haslam A, et al. J Gerontol A Biol Sci Med Sci. 2012 Jan;67(1):100-6. doi: 10.1093/gerona/glr151. Epub 2011 Sep 5. J Gerontol A Biol Sci Med Sci. 2012. PMID: 21896502 Free PMC article.

3

Vitamin D status is associated with grip strength in centenarians.

Haslam A, Johnson MA, Hausman DB, Cress ME, Houston DK, Davey A, Poon LW; Georgia Centenarian Study. Haslam A, et al. J Nutr Gerontol Geriatr. 2014;33(1):35-46. doi: 10.1080/21551197.2013.867825. J Nutr Gerontol Geriatr. 2014. PMID: 24597995

4

Association between dietary pattern scores and the prevalence of colorectal adenoma considering population subgroups.

Haslam A, Wagner Robb S, Hébert JR, Huang H, Ebell MH. Haslam A, et al. Nutr Diet. 2018 Apr;75(2):167-175. doi: 10.1111/1747-0080.12400. Epub 2017 Dec 26. Nutr Diet. 2018. PMID: 29280253

5

When is crossover desirable in cancer drug trials and when is it problematic?

Haslam A, Prasad V. Haslam A, et al. Ann Oncol. 2018 May 1;29(5):1079-1081. doi: 10.1093/annonc/mdy116. Ann Oncol. 2018. PMID: 29648572 Free PMC article. No abstract available.

6

Multivitamins Do Not Reduce Cardiovascular Disease and Mortality and Should Not Be Taken for This Purpose: How Do We Know That?

Haslam A, Prasad V. Haslam A, et al. Circ Cardiovasc Qual Outcomes. 2018 Jul;11(7):e004886. doi: 10.1161/CIRCOUTCOMES.118.004886. Circ Cardiovasc Qual Outcomes. 2018. PMID: 29991647 No abstract available.

7

A systematic review of trial-level meta-analyses measuring the strength of association between surrogate end-points and overall survival in oncology.

Haslam A, Hey SP, Gill J, Prasad V. Haslam A, et al. Eur J Cancer. 2019 Jan;106:196-211. doi: 10.1016/j.ejca.2018.11.012. Epub 2018 Dec 5. Eur J Cancer. 2019. PMID: 30528804

8

Where Does the Blame for High Health Care Costs Go? An Empirical Analysis of Newspaper and Journal Articles Criticizing Health Care Costs.

Haslam A, Crain T, Gill J, Herrera-Perez D, Prasad V. Haslam A, et al. Am J Med. 2019 Jun;132(6):718-721. doi: 10.1016/j.amjmed.2018.12.019. Epub 2019 Jan 9. Am J Med. 2019. PMID: 30639552

9

Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs.

Haslam A, Prasad V. Haslam A, et al. JAMA Netw Open. 2019 May 3;2(5):e192535. doi: 10.1001/jamanetworkopen.2019.2535. JAMA Netw Open. 2019. PMID: 31050774 Free PMC article.

10

Confirmatory Trials for Drugs Approved on a Single Trial.

Haslam A, Prasad V. Haslam A, et al. Circ Cardiovasc Qual Outcomes. 2019 Jun;12(6):e005494. doi: 10.1161/CIRCOUTCOMES.119.005494. Epub 2019 May 29. Circ Cardiovasc Qual Outcomes. 2019. PMID: 31137954 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

145 results

Search Page